Axovant Sciences Ltd (AXON) is a publicly traded aerospace and defence business based in the US. In the week up to 7 March Axon Enterprise shares surged 10.95% to a closing position of $222.24. Over the last 12 months, Axon Enterprise's share price has risen by 13.28% from $134.37. Axon Enterprise is listed on the NASDAQ and employs 2,821 staff. All prices are listed in US Dollars.
Best for
0% commission
BEST FOR
Welcome Bonus
Best for
Beginner investments
Best for
Beginners
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Customer rating | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|---|
|
★★★★★ | £0 | £1 | £2.80 £625.00 total |
Capital at risk |
|
★★★★★ | £0 | $50 | £3.11 £625.31 total |
Capital at risk |
|
★★★★★ | £0 | £250 | £11.33 £633.53 total |
Capital at risk |
|
Not yet rated | £0 | No minimum | £3.11 £625.31 total |
Capital at risk |
 |
★★★★★ | £0 | No minimum | £6.22 £628.42 total |
Capital at risk |
 |
★★★★★ | £0 | £1 | £18.17 £640.37 total |
Capital at risk |
 |
★★★★★ | £0 | £0.01 | £0.62 £622.82 total |
Capital at risk |
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Axon Enterprise P/E ratio, PEG ratio and EBITDA
Axon Enterprise's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 106x. In other words, Axon Enterprise shares trade at around 106x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Axon Enterprise's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.86. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Axon Enterprise's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Axon Enterprise's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $122.9 million (£0.0 million).
The EBITDA is a measure of a Axon Enterprise's overall financial performance and is widely used to measure a its profitability.
Join 50,000 subscribers who are notified about expert money tips. Plus a chance to win £500!
By signing up you agree to receive emails from Finder and to the privacy policy and terms & conditions.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to buy shares in STAG Industrial? We explain how and compare a range of providers that can give you access to many brands, including STAG Industrial.
Ever wondered how to buy shares in Camtek? We explain how and compare a range of providers that can give you access to many brands, including Camtek.
Ever wondered how to buy shares in Axalta Coating Systems? We explain how and compare a range of providers that can give you access to many brands, including Axalta Coating Systems.
Ever wondered how to buy shares in The Eastern Company? We explain how and compare a range of providers that can give you access to many brands, including The Eastern Company.
Ever wondered how to buy shares in Ultralife? We explain how and compare a range of providers that can give you access to many brands, including Ultralife.
Ever wondered how to buy shares in Sensient Technologies? We explain how and compare a range of providers that can give you access to many brands, including Sensient Technologies.
Ever wondered how to buy shares in Covanta Holding? We explain how and compare a range of providers that can give you access to many brands, including Covanta Holding.
Ever wondered how to buy shares in Cabot Microelectronics? We explain how and compare a range of providers that can give you access to many brands, including Cabot Microelectronics.
Ever wondered how to buy shares in Broadwind? We explain how and compare a range of providers that can give you access to many brands, including Broadwind.
Ever wondered how to buy shares in Veeco Instruments? We explain how and compare a range of providers that can give you access to many brands, including Veeco Instruments.